Skip to content
★ Sign in to follow
BJ

Brad J. Pyatt

MusclePharm Corp
Total declarations
73
Company
1
▲ Purchases (67 ops.)
€482k
▼ Sales (0 ops.)
—

Latest filing published 07 Oct 2015 for MusclePharm Corp.

Insider track record

Disclosed buys
67
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
67

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Brad J. Pyatt: trading record in brief

All filings by Brad J. Pyatt on record concern MusclePharm Corp. We count 73 filings; the first trade dates from 18 October 2010 and the latest from 5 October 2015.

Every open-market trade on record is a purchase: 67 purchases worth €482k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 share grants.

Half of the purchases are above €2,653 and half below.

On 7 October 2015 came the latest disclosure, a transaction in MusclePharm Corp. The clock since the last published purchase (20 November 2014) now reads 4,371 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Brad J. Pyatt

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations73 total
  • ●
    Chief Executive OfficerExecutivesMusclePharm Corp
    0SEC
    90,418 sharesCommon StockSEC:0001144204-15-058439:0
  • ●
    Chief Executive OfficerExecutivesMusclePharm Corp
    0SEC
    100,000 sharesCommon StockSEC:0001144204-15-028801:0
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    10,945 USD0SEC
    1,100 shares@ US$9.95Common StockSEC:0001144204-14-070082:0
    Canonical exit: 18 Feb 2015 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    998 USD0SEC
    100 shares@ US$9.98Common StockSEC:0001144204-14-070082:1
    Canonical exit: 18 Feb 2015 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    16,983 USD0SEC
    1,700 shares@ US$9.99Common StockSEC:0001144204-14-070082:2
    Canonical exit: 18 Feb 2015 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    1,002 USD0SEC
    100 shares@ US$10.02Common StockSEC:0001144204-14-070082:3
    Canonical exit: 18 Feb 2015 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    1,005 USD0SEC
    100 shares@ US$10.05Common StockSEC:0001144204-14-070082:4
    Canonical exit: 18 Feb 2015 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    67,938 USD0SEC
    6,700 shares@ US$10.14Common StockSEC:0001144204-14-070082:5
    Canonical exit: 18 Feb 2015 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    1,015 USD0SEC
    100 shares@ US$10.15Common StockSEC:0001144204-14-070082:6
    Canonical exit: 18 Feb 2015 (T+90)
  • ◆
    Chief Executive OfficerExecutivesMusclePharm Corp
    7M USD0SEC
    500,000 shares@ US$13.00Common StockSEC:0001209191-14-069231:0
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    6,800 USD0SEC
    500 shares@ US$13.60Common StockSEC:0001144204-14-054533:0
    Canonical exit: 4 Dec 2014 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    2,430 USD0SEC
    200 shares@ US$12.15Common StockSEC:0001144204-14-052123:0
    Canonical exit: 19 Nov 2014 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    47,920 USD0SEC
    3,944 shares@ US$12.15Common StockSEC:0001144204-14-052123:1
    Canonical exit: 20 Nov 2014 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    12,150 USD0SEC
    1,000 shares@ US$12.15Common StockSEC:0001144204-14-052123:2
    Canonical exit: 20 Nov 2014 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    2,600 USD0SEC
    214 shares@ US$12.15Common StockSEC:0001144204-14-052123:3
    Canonical exit: 20 Nov 2014 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    5,750 USD0SEC
    500 shares@ US$11.50Common StockSEC:0001144204-14-050504:0
    Canonical exit: 12 Nov 2014 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    11,500 USD0SEC
    1,000 shares@ US$11.50Common StockSEC:0001144204-14-050504:1
    Canonical exit: 12 Nov 2014 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    11,450 USD0SEC
    1,000 shares@ US$11.45Common StockSEC:0001144204-14-050504:2
    Canonical exit: 12 Nov 2014 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    16,875 USD0SEC
    1,500 shares@ US$11.25Common StockSEC:0001144204-14-048170:0
    Canonical exit: 6 Nov 2014 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    47,460 USD0SEC
    4,200 shares@ US$11.30Common StockSEC:0001144204-14-048170:1
    Canonical exit: 6 Nov 2014 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    2,117 USD0SEC
    189 shares@ US$11.20Common StockSEC:0001144204-14-048170:2
    Canonical exit: 6 Nov 2014 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    40,377 USD0SEC
    3,511 shares@ US$11.50Common StockSEC:0001144204-14-048170:3
    Canonical exit: 6 Nov 2014 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    27,875 USD0SEC
    2,500 shares@ US$11.15Common StockSEC:0001144204-14-048170:4
    Canonical exit: 6 Nov 2014 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    12,166 USD0SEC
    1,100 shares@ US$11.06Common StockSEC:0001144204-14-048170:5
    Canonical exit: 6 Nov 2014 (T+90)
  • ▲
    Chief Executive OfficerExecutivesMusclePharm Corp
    22,200 USD0SEC
    2,000 shares@ US$11.10Common StockSEC:0001144204-14-048170:6
    Canonical exit: 6 Nov 2014 (T+90)

25 of 73 declarations